DermTech, Inc.

OTCPK:DMTK.Q 주식 보고서

시가총액: US$35.0

DermTech 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간5.3yrs

최근 관리 업데이트

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

CEO

DermTech 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

리더십 팀

이름위치테뉴어보상소유권
Burkhard Jansen
Presidentno dataUS$480.83k데이터 없음
Jeremy Teraoka
Head of Financeno data데이터 없음데이터 없음
Steve Kunszabo
Senior Director of Investor Relationsno data데이터 없음데이터 없음
Jennifer Eilemberg
Chief Compliance Officer2.3yrs데이터 없음데이터 없음
Loren Clarke
Chief Medical Officer3.4yrs데이터 없음데이터 없음

2.3yrs

평균 재임 기간

경험이 풍부한 관리: DMTK.Q 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Herman Rosenman
Independent Director5.3yrsUS$149.64k0.28%
$ 0.1
Kirk Malloy
Independent Director2.3yrsUS$136.64k0.094%
$ 0.03
Matthew Posard
Independent Chairman of the Board8.3yrsUS$188.64k0.35%
$ 0.1
Mark Capone
Independent Director2.3yrsUS$139.64k0.081%
$ 0.03
Cynthia Collins
Independent Director5.3yrsUS$156.64k0.20%
$ 0.07
Daniel Siegel
Member of Clinical Advisory Board7.1yrs데이터 없음데이터 없음
Neal Bhatia
Member of Clinical Advisory Boardno data데이터 없음데이터 없음
Nathalie Keraudy
Independent Director3.1yrsUS$134.64k0.092%
$ 0.03
Laura Ferris
Member of Clinical Advisory Boardno data데이터 없음데이터 없음
Maral Skelsey
Member of Clinical Advisory Board5.8yrs데이터 없음데이터 없음
Mark Kaufmann
Member of Clinical Advisory Boardno data데이터 없음데이터 없음
Lorraine Rosamilia
Member of Clinical Advisory Boardno data데이터 없음데이터 없음

5.3yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: DMTK.Q 의 이사회는 경험(평균 재직 기간 5.3 년)으로 간주됩니다.